In contrast, AMPK activation can also enhance neuronal excitability and ameliorate hyposensitivity, including mechanical or thermal responses, by inhibiting the Kv2.1 channel in animal models of long-term diabetic neuropathy [127], suggesting a dual beneficial effect of AMPK activators such as metformin in patients with diabetes. Here, PRKAA1 is linked to diabetes mellitus.